LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 9 of 15: Cell count and normalized growth rate inhibition values within biological replicate 2. - Dataset (ID:20246)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hs 578T | SNS-032 | 0.12 | uM | LJP6 | 3 | H17 | 72 | hr | 765 | 421 | 3066 | 0.1373 | -0.2579 |
Hs 578T | CGP60474 | 0.37 | uM | LJP6 | 3 | G04 | 72 | hr | 765 | 435 | 3066 | 0.1419 | -0.2457 |
Hs 578T | Sirolimus | 0.12 | uM | LJP6 | 3 | L17 | 72 | hr | 765 | 1938 | 3066 | 0.6321 | 0.5906 |
Hs 578T | Dasatinib | 0.37 | uM | LJP6 | 3 | I04 | 72 | hr | 765 | 502 | 3066 | 0.1637 | -0.1897 |
Hs 578T | NVP-TAE684 | 3.33 | uM | LJP6 | 3 | K14 | 72 | hr | 765 | 792 | 3066 | 0.2583 | 0.0174 |
Hs 578T | KIN001-043 | 0.12 | uM | LJP6 | 3 | C11 | 72 | hr | 765 | 3173 | 3066 | 1.0349 | 1.0346 |
Hs 578T | PD173074 | 0.12 | uM | LJP6 | 3 | I11 | 72 | hr | 765 | 2277 | 3066 | 0.7427 | 0.7239 |
Hs 578T | CGP60474 | 10 | uM | LJP6 | 3 | G01 | 72 | hr | 765 | 263 | 3066 | 0.0858 | -0.4133 |
Hs 578T | BI-2536 | 0.12 | uM | LJP6 | 3 | D17 | 72 | hr | 765 | 463 | 3066 | 0.1510 | -0.2218 |
Hs 578T | A443654 | 10 | uM | LJP6 | 3 | I19 | 72 | hr | 765 | 247 | 3066 | 0.0806 | -0.4314 |
Hs 578T | R406 | 0.12 | uM | LJP6 | 3 | C17 | 72 | hr | 765 | 2777 | 3066 | 0.9057 | 0.9035 |
Hs 578T | Imatinib | 10 | uM | LJP6 | 3 | N13 | 72 | hr | 765 | 3368 | 3066 | 1.0985 | 1.0961 |
Hs 578T | Imatinib | 1.11 | uM | LJP6 | 3 | N15 | 72 | hr | 765 | 3284 | 3066 | 1.0711 | 1.0698 |
Hs 578T | AT-7519 | 1.11 | uM | LJP6 | 3 | K03 | 72 | hr | 765 | 411 | 3066 | 0.1341 | -0.2667 |
Hs 578T | AT-7519 | 0.04 | uM | LJP6 | 3 | K06 | 72 | hr | 765 | 2983 | 3066 | 0.9729 | 0.9728 |
Hs 578T | ZSTK474 | 1.11 | uM | LJP6 | 3 | M15 | 72 | hr | 765 | 1296 | 3066 | 0.4227 | 0.3011 |
Hs 578T | R406 | 1.11 | uM | LJP6 | 3 | C15 | 72 | hr | 765 | 2327 | 3066 | 0.7590 | 0.7427 |
Hs 578T | AT-7519 | 0.12 | uM | LJP6 | 3 | K05 | 72 | hr | 765 | 2246 | 3066 | 0.7326 | 0.7122 |
Hs 578T | CGP60474 | 3.33 | uM | LJP6 | 3 | G02 | 72 | hr | 765 | 356 | 3066 | 0.1161 | -0.3175 |
Hs 578T | AT-7519 | 0.37 | uM | LJP6 | 3 | K04 | 72 | hr | 765 | 475 | 3066 | 0.1549 | -0.2118 |
Hs 578T | Dasatinib | 3.33 | uM | LJP6 | 3 | I02 | 72 | hr | 765 | 463 | 3066 | 0.1510 | -0.2218 |
Hs 578T | AT-7519 | 3.33 | uM | LJP6 | 3 | K02 | 72 | hr | 765 | 333 | 3066 | 0.1086 | -0.3399 |
Hs 578T | AT-7519 | 10 | uM | LJP6 | 3 | K01 | 72 | hr | 765 | 401 | 3066 | 0.1308 | -0.2757 |
Hs 578T | Afatinib | 3.33 | uM | LJP6 | 3 | G20 | 72 | hr | 765 | 2638 | 3066 | 0.8604 | 0.8554 |
Hs 578T | Afatinib | 1.11 | uM | LJP6 | 3 | G21 | 72 | hr | 765 | 2657 | 3066 | 0.8666 | 0.8620 |